Patents-Review.com
ClassID:

21086 ⎘

A61K39/0266 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Bacterial antigens; Enterobacteriales, e.g. Enterobacter Klebsiella

Recent Application in this class:
#1
20260144856
2026-05-28

VACCINE AGAINST KLEBSIELLA PNEUMONIAE

 #2
20260124286
2026-05-07

E. COLI FIMH MUTANTS AND USES THEREOF

 #3
20260108489
2026-04-23

TOPICAL NASAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PROPHYLAXIS OF CHRONIC RHINOSINUSITIS (CRS)

 #4
20260102479
2026-04-16

METHOD FOR THE PURIFICATION OF CAPSULAR POLYSACCHARIDES

 #5
20250381257
2025-12-18

VACCINE

 #6
20250281590
2025-09-11

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF

 #7
20250222089
2025-07-10

KLEBSIELLA VACCINE AND METHODS OF USE

 #8
20250205325
2025-06-26

Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae

 #9
20250186571
2025-06-12

EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS

 #10
20250177517
2025-06-05

TRIPLE VACCINE PROTECTS AGAINST BACTERIAL AND FUNGAL PATHOGENS VIA TRAINED IMMUNITY

 #11
20250177507
2025-06-05

Multivalent Vaccine Compositions

 #12
20250114442
2025-04-10

ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF

 #13
20240424046
2024-12-26

METHOD FOR TREATING A SKIN WOUND CONTAINING KLEBSIELLA PNEUMONIAE

 #14
20240325513
2024-10-03

ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF

 #15
20240294582
2024-09-05

FimH Mutant, Compositions Therewith And Use Thereof

 #16
20240262870
2024-08-08

GLYCOSYLATED COMP PILIN VARIANTS, METHODS OF MAKING AND USES THEREOF

 #17
20240226260
2024-07-11

VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS

 #18
20240216494
2024-07-04

PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING KLEBSIELLA PROTEINS AND METHODS OF USE

 #19
20240191209
2024-06-13

VACCINE FOR IMMUNOCOMPROMISED HOSTS

 #20
20240189409
2024-06-13

Personalized Site-Specific Immunomodulation

 #21
20240156936
2024-05-16

LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS HETEROLOGOUS OUTER MEMBRANE PROTEIN ANTIGENS AND METHODS OF USE THEREOF

 #22
20240131135
2024-04-25

VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS

 #23
20240091330
2024-03-21

Anti-Microbial Immunomodulation

 #24
20240066109
2024-02-29

Klebsiella Pneumoniae O-Antigen Glycosylated Proteins and Methods of Making and Uses Thereof

 #25
20240041962
2024-02-08

Antibacterial treatment method for a patient with a skin wound

 #26
20230414740
2023-12-28

IMMUNOGENIC COMPOSITIONS

 #27
20230355751
2023-11-09

COMPOSITIONS AND METHODS FOR A MULTI-ADJUVANT ONLY APPROACH TO IMMUNOPROPHYLAXIS FOR PREVENTING INFECTIONS

 #28
20230346925
2023-11-02

Triple vaccine protects against bacterial and fungal pathogens via trained immunity

 #29
20230338452
2023-10-26

Ointment-based skin wound treatment method

 #30
20230293657
2023-09-21

VACCINE

 #31
20230293656
2023-09-21

Bacterium capable of inducing TH1 cells

 #32
20230226175
2023-07-20

MODIFIED EXOTOXIN A PROTEINS

 #33
20230122752
2023-04-20

Vaccine against klebsiella pneumoniae

 #34
20230049056
2023-02-16

FimH mutant, compositions therewith and use thereof

 #35
20220354943
2022-11-10

Therapeutic Agent Effectiveness and its Route of Adminstration

 #36
20220257743
2022-08-18

vaccine and methods of use

 #37
20220218774
2022-07-14

Method for treating a skin wound having a infection

 #38
20220202923
2022-06-30

E. COLI FIMH MUTANTS AND USES THEREOF

 #39
20220160857
2022-05-26

MULTIVALENT VACCINES DERIVED FROM KLEBSIELLA OUT MEMBRANE PROTEINS

 #40
20220152181
2022-05-19

compositions and methods thereof

 #41
20220072118
2022-03-10

Immunogenic compositions

 #42
20220049229
2022-02-17

Vaccine for immunocompromised hosts

 #43
20210386845
2021-12-16

Vaccine against

#44
20210330776
2021-10-28

Proteins and immunizing compositions containing proteins and methods of use

 #45
20210324017
2021-10-21

Glycosylated ComP pilin variants, methods of making and uses thereof

 #46
20210268095
2021-09-02

ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF

 #47
20210221856
2021-07-22

FimH mutant, compositions therewith and use thereof

 #48
20210198304
2021-07-01

Vaccine against

#49
20210138057
2021-05-13

Anti-microbial immunomodulation

 #50
20210123108
2021-04-29

strain inducing inflammation in liver

 #51
20210052713
2021-02-25

Proteins and nucleic acids useful in vaccines targeting

#52
20210030861
2021-02-04

from minks and its application

 #53
20200353075
2020-11-12

Compositions and methods for a multi-adjuvant only approach to immunoprophylaxis for preventing infections

 #54
20200323973
2020-10-15

Epitope-targeted peptide immunostimulants

 #55
20200179501
2020-06-11

Live vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof

 #56
20200121784
2020-04-23

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

 #57
20200113989
2020-04-16

Personalized Site-Specific Immunomodulation

 #58
20200038497
2020-02-06

capsule polysaccharide vaccines

 #59
20200023049
2020-01-23

Proteins and nucleic acids useful in vaccines targeting

#60
20190298787
2019-10-03

Antimicrobial extracts of Boswellia and thyme

 #61
20190247484
2019-08-15

Anti-microbial immunomodulation

 #62
20190134172
2019-05-09

Therapeutically triggering an innate immune response in a target tissue

 #63
20190070281
2019-03-07

Proteins and immunizing compositions containing proteins and methods of use

 #64
20190062411
2019-02-28

MRKA POLYPEPTIDES, ANTIBODIES, AND USES THEREOF

 #65
20190015496
2019-01-17

Proteins and nucleic acids useful in vaccines targeting

#66
20180194812
2018-07-12

Broad spectrum conjugate vaccine to prevent klebsiella pneumoniae and pseudomonas aeruginosa infections

 #67
20180078630
2018-03-22

Vaccines against carbapenem-resistant

#68
20180043004
2018-02-15

Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)

 #69
20170368166
2017-12-28

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

 #70
20170260240
2017-09-14

Broad spectrum conjugate vaccine to prevent and infections

 #71
20170191040
2017-07-06

Vaccine for immunocompromised hosts

 #72
20170087237
2017-03-30

Anti-microbial immunomodulation

 #73
20170073397
2017-03-16

MrkA Polypeptides, Antibodies, and Uses Thereof

 #74
20170056497
2017-03-02

Method of treating protozoal gastrointestinal disorders in immunocompromised patients

 #75
20160263209
2016-09-15

Tissue targeted antigenic activation of the immune response to treat cancers

 #76
20160136285
2016-05-19

AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA

 #77
20160120918
2016-05-05

Compositions and methods for treatment of microbial infections

 #78
20160008454
2016-01-14

Compositions and methods for treatment of microbial infections

 #79
20150343050
2015-12-03

Tissue targeted antigenic activation of the immune response to treat cancers

 #80
20150165019
2015-06-18

Saccharide Conjugate Vaccines

 #81
20150150958
2015-06-04

Compositions and methods for treatment of microbial infections

 #82
20150086561
2015-03-26

BINDING MOIETIES FOR BIOFILM REMEDIATION

 #83
20150050311
2015-02-19

NOVEL METHOD FOR THE PREPARATION OF A STRAIN-ADAPTED VACCINE

 #84
20140212448
2014-07-31

KLEBSIELLA ANTIGENS

 #85
20140093536
2014-04-03

Compositions and methods for treatment of microbial infections

 #86
20130295137
2013-11-07

Compositions and methods for treatment of microbial infections

 #87
20130251748
2013-09-26

USE OF OUTER MEMBRANE PORIN K36 PROTEIN (OMPK36) IN TREATMENT/PREVENTION/DIAGNOSIS OF ENTEROBACTERIACEAE INFECTION

 #88
20130230526
2013-09-05

KLEBSIELLA ANTIGENS

 #89
20130177593
2013-07-11

Personalized site-specific immunomodulation

 #90
20130011403
2013-01-10

antigens

 #91
20120258135
2012-10-11

Immunogenic anti-inflammatory compositions

 #92
20120100178
2012-04-26

Compositions and methods for treatment of microbial infections

 #93
20120076819
2012-03-29

Compositions and methods for treating of microbial infections

 #94
20110236410
2011-09-29

antigens

 #95
20110195093
2011-08-11

Tissue targeted antigenic activation of the immune response to treat cancers

 #96
20100158941
2010-06-24

Compositions and methods for treating microbial infections

 #97
20100129408
2010-05-27

KLEBSIELLA PNEUMONIAE ATTENUATED VIRULENCE MUTANT AND METHOD OF PRODUCTION

 #98
20100003233
2010-01-07

Compositions and methods for treatment of microbial infections

 #99
20080260773
2008-10-23

Saccharide Conjugate Vaccines

 #100
20080199445
2008-08-21

Compositions and methods for treatment of microbial infections

 #101
20070104733
2007-05-10

TISSUE TARGETED ANTIGENIC ACTIVATION OF THE IMMUNE RESPONSE TO CANCERS

 #102
20050238670
2005-10-27

Compositions and methods for treatment of microbial infections